Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups
- PMID: 31200818
- DOI: 10.1016/j.lungcan.2019.05.017
Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups
Abstract
Objectives: Negative effusion cytology is more common in certain forms of Malignant Pleural Effusion (MPE) and results in pathway delay. Local Anaesthetic Thoracoscopy (LAT) is extremely sensitive and safe but cannot be offered to all. A stratified pathway, including 'Direct to LAT' in selected cases could enhance patient experience but requires reliable baseline predictors of unhelpful cytology, including both negative (no malignant cells) and incomplete results (malignant cells identified but predictive markers failed), since pleural biopsies will be required in the latter for optimal management. This retrospective analysis of a prospective multi-centre study, sought to identify baseline features for pathway rationalization.
Materials and methods: 363/638 (57%) of patients recruited to the DIAPHRAGM study (ISRCTN10079972) were included. Prospective data, including final diagnoses, asbestos exposure and fluid cytology results were supplemented by retrospective Computed Tomography (CT) and predictive marker reports. Independent predictors of negative and incomplete cytology were determined by multivariable logistic regression. Contingency tables were used to assess diagnostic value of cytology in associated phenotypes.
Results: 238/363 (66%) patients were diagnosed with MPE (18 tumour types). Fluid cytology was negative in 151/238 (63%) and independently associated with asbestos-exposure (Odds Ratio (OR) 5.34) and a malignant CT (OR 2.25). When both features were recorded the sensitivity and negative predictive value of fluid cytology were 19% (95% CI 11-30%) and 9% (95% CI 4-20%)), respectively. Cytology was incomplete in 34/238 (14%), i.e. 47% of positive cytology cases) but was not associated with any baseline feature. ORs for incomplete cytology in Ovarian, Breast, Renal and Lung Cancer were 83, 22, 21 and 9, respectively.
Conclusion: Negative cytology is extremely likely in patients with asbestos exposure and a malignant CT report. A 'Direct-to-LAT' approach may be appropriate in this setting. No baseline predictors of incomplete cytology were identified.
Keywords: Cytology; Lung cancer; Malignant pleural effusion; Mesothelioma; Pleural effusion.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy.Lung Cancer. 2018 Apr;118:48-56. doi: 10.1016/j.lungcan.2018.01.014. Epub 2018 Feb 3. Lung Cancer. 2018. PMID: 29572002 Free PMC article.
-
Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.Asian Pac J Cancer Prev. 2022 Jan 1;23(1):25-31. doi: 10.31557/APJCP.2022.23.1.25. Asian Pac J Cancer Prev. 2022. PMID: 35092368 Free PMC article.
-
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.Clin Respir J. 2018 Mar;12(3):1011-1016. doi: 10.1111/crj.12619. Epub 2017 Mar 15. Clin Respir J. 2018. PMID: 28245530
-
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.Thorax. 2023 Jan;78(1):32-40. doi: 10.1136/thoraxjnl-2021-217959. Epub 2022 Feb 2. Thorax. 2023. PMID: 35110369
-
Clinical and prognostic features of erionite-induced malignant mesothelioma.Yonsei Med J. 2015 Mar;56(2):311-23. doi: 10.3349/ymj.2015.56.2.311. Yonsei Med J. 2015. PMID: 25683976 Free PMC article. Review.
Cited by
-
A review of the outcomes of rigid medical thoracoscopy in a large UK district general hospital.Pleura Peritoneum. 2020 Nov 2;5(4):20200131. doi: 10.1515/pp-2020-0131. eCollection 2020 Nov. Pleura Peritoneum. 2020. PMID: 33575462 Free PMC article.
-
Diagnostics in Pleural Disease.Diagnostics (Basel). 2020 Dec 4;10(12):1046. doi: 10.3390/diagnostics10121046. Diagnostics (Basel). 2020. PMID: 33291748 Free PMC article. Review.
-
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis.Eur Respir Rev. 2022 Dec 21;31(166):220053. doi: 10.1183/16000617.0053-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36543349 Free PMC article.
-
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma.Cancers (Basel). 2021 Jun 30;13(13):3291. doi: 10.3390/cancers13133291. Cancers (Basel). 2021. PMID: 34209209 Free PMC article. Review.
-
A Diagnostic Approach to Malignant Pleural Mesothelioma.Pulm Ther. 2025 Jun 11. doi: 10.1007/s41030-025-00301-6. Online ahead of print. Pulm Ther. 2025. PMID: 40498282
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials